Article
IDH1-mutated Crohn's disease-associated small bowel adenocarcinomas: Distinctive pathological features and association with MGMT methylation and serrated-type dysplasia.
Histopathology - 1 Feb 2024
Guerini Camilla, Furlan Daniela, Ferrario Giuseppina, Grillo Federica, Libera Laura, Arpa Giovanni, Klersy Catherine, Lenti Marco V, Riboni Roberta, Solcia Enrico, Fassan Matteo, Mastracci Luca, Ardizzone Sandro, Moens Annick, De Hertogh Gert, Ferrante Marc, Graham Rondell P, Sessa Fausto, Paulli Marco, Di Sabatino Antonio, Vanoli Alessandro
Abstract excerpt
AIMS: Patients with Crohn's disease (CrD) have an elevated risk for the development of small bowel adenocarcinomas (SBAs). Actionable isocitrate dehydrogenase 1 (IDH1) mutations have been reported to be more frequent in CrD-SBAs than in sporadic SBAs. The present study aimed to investigate the clinicopathological and immunophenotypical features, as well as methylation profiles, of IDH1-mutated CrD-SBAs. METHODS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
